| Title | Molecular Therapy - Oncolytics |
| Abbreviation | Mol. Ther. - Oncolytics |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Molecular Medicine (Q1); Oncology (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2) |
| h-index | 42 |
| Overall Rank/Ranking | 2269 |
| SCImago Journal Rank (SJR) | 1.494 |
| Impact Score | 5.35 |
| Publisher | Cell Press |
| Country | United Kingdom |
| ISSN | 23727705 |
| Best Quartile | Q1 |
| Coverage History | 2014-2023 |
Molecular Therapy - Oncolytics is a journal covering the technologies/fields/categories related to Molecular Medicine (Q1); Oncology (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2). It is published by Cell Press. The overall rank of Molecular Therapy - Oncolytics is 2269. According to SCImago Journal Rank (SJR), this journal is ranked 1.494. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 42. The best quartile for this journal is Q1.
The ISSN of Molecular Therapy - Oncolytics journal is 23727705. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular Therapy - Oncolytics is cited by a total of 2595 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Molecular Therapy - Oncolytics is 5.35, which is computed in 2024 as per its definition. Molecular Therapy - Oncolytics IF is decreased by a factor of 0.21 and approximate percentage change is -3.78% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Molecular Therapy - Oncolytics is 5.35. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 5.35 |
| 2022 | 5.56 |
| 2021 | 6.06 |
| 2020 | 6.19 |
| 2019 | 4.03 |
| 2018 | 5.79 |
| 2017 | 3.87 |
| 2016 | 1.39 |
| 2015 | 0.67 |
| 2014 | 0.00 |
Molecular Therapy - Oncolytics has an h-index of 42. It means 42 articles of this journal have more than 42 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Molecular Therapy - Oncolytics is 23727705. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Molecular Therapy - Oncolytics is 2269. According to SCImago Journal Rank (SJR), this journal is ranked 1.494. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.494 |
| 2022 | 1.339 |
| 2021 | 1.530 |
| 2020 | 1.424 |
| 2019 | 1.982 |
| 2018 | 1.753 |
| 2017 | 1.193 |
| 2016 | 0.452 |
| 2015 | 0.272 |
| 2014 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2269 |
| 2022 | 2594 |
| 2021 | 2029 |
| 2020 | 2477 |
| 2019 | 1340 |
| 2018 | 1722 |
| 2017 | 3351 |
| 2016 | 10068 |
| 2015 | 14308 |
| 2014 | 32541 |
Molecular Therapy - Oncolytics is published by Cell Press. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2014-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Molecular Therapy - Oncolytics is Mol. Ther. - Oncolytics. This abbreviation ('Mol. Ther. - Oncolytics') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Molecular Medicine (Q1); Oncology (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Molecular Therapy - Oncolytics latest impact IF is 5.35. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 6.19 (2020) and 0.00 (2014), respectively, in the last 10 years. Moreover, its average IS is 3.89 in the previous 10 years.
The Molecular Therapy - Oncolytics has an SJR (SCImago Journal Rank) of 1.494, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.982 in 2019 and the lowest being in 2014. Furthermore, the average SJR of the Molecular Therapy - Oncolytics over the previous 10-year period stands at 3.89.
The latest h-index of the Molecular Therapy - Oncolytics is 42.
The Molecular Therapy - Oncolytics is published by the Cell Press, with its country of publication being the United Kingdom.
The Molecular Therapy - Oncolytics is currently ranked 2269 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1340 in 2019 and its lowest position of 32541 in 2014.
The standard ISO4 abbreviation for the Molecular Therapy - Oncolytics is Mol. Ther. - Oncolytics.
Molecular Therapy - Oncolytics is classified as a journal that the Cell Press publishes.
The Molecular Therapy - Oncolytics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Molecular Therapy - Oncolytics is assigned the following International Standard Serial Numbers (ISSN): 23727705.
The best quartile for the Molecular Therapy - Oncolytics is Q1 (2023).
The Molecular Therapy - Oncolytics coverage history can be summarized as follows: 2014-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 13847 | Thieme Medical Publishers, Inc. | 40 | 0.59 |
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Journal of Classical Sociology | journal | 15798 | SAGE Publications Ltd | 30 | 1.30 |
| Discourse | journal | 6196 | Routledge | 65 | 2.36 |
| Modern Language Journal | journal | 1100 | Wiley-Blackwell | 112 | 3.93 |
| Howard Journal of Communications | journal | 10151 | Taylor and Francis Ltd. | 39 | 1.66 |
| Built Environment | journal | 12809 | Alexandrine Press | 46 | 1.18 |
| Asian Textile Journal | trade journal | 27997 | G P S Kwatra | 11 | 0.03 |
| Journal of Immigrant and Refugee Studies | journal | 8890 | Routledge | 36 | 2.04 |
| East African journal of public health | journal | 19634 | East African Public Health Association | 23 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 5.35 |
| 2022 | 5.56 |
| 2021 | 6.06 |
| 2020 | 6.19 |
| 2019 | 4.03 |
| 2018 | 5.79 |
| 2017 | 3.87 |
| 2016 | 1.39 |
| 2015 | 0.67 |
| 2014 | 0.00 |
